Timolol Maleate (Ophthalmic)

11 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

910.0%

Death Rate

Active Ingredients

Timolol Maleate (Ophthalmic)

Administration Routes

OphthalmicUnknownIntraocular

Species Affected

Dog 9

Human 1

Cat 1

Most Affected Breeds

Shih Tzu 2

Spaniel - Cocker English 1

Hound - Basset 1

Maltese 1

Poodle (unspecified) 1

Unknown 1

Siamese 1

Poodle - Miniature 1

Newfoundland 1

Crossbred Canine/dog 1

Most Reported Reactions

Neutrophilia 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Decreased appetite 2

Gagging 2

Blindness 2

Cough 2

Abdominal pain 2

Abnormal pupil light reflex 2

Other abnormal test result NOS 2

Abnormal radiograph finding 2

Loose stool 2

Elevated serum alkaline phosphatase (SAP) 2

Outcome Breakdown

Ongoing

4 (36.4%)

Recovered/Normal

3 (27.3%)

Recovered with Sequela

2 (18.2%)

Euthanized

1 (9.1%)

Outcome Unknown

1 (9.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.